Clinical Pharmacology of Miami
Clinical Pharmacology of Miami
Miami, Florida, United States8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of LY3537031 in Overweight, Obese, and Healthy Participants | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 | 2026-09-30 | NCT06606106 | |
| Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Phase 1 | 2026-09-28 | NCT07399678 | |
| A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 1 diabetes mellitus | Recruiting | Phase 1 | 2026-09-23 | NCT07803744 | |
| Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib | Healthy; Hepatic Impairment | Recruiting | Phase 1 | 2026-09-21 | NCT06997276 | |
| A Study of TLC590 for Postsurgical Pain Following Bunionectomy | Bunion, Foot Deformities, Foot Deformities, Acquired, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms, musculoskeletal system disorder | Active, not recruiting | Phase 3 | 2026-07-02 | NCT07222748 | |
| A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 1 | 2026-05-06 | NCT07568678 | |
| A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function | Healthy Participants | Recruiting | Phase 1 | 2026-04-03 | NCT07231991 | |
| Evaluation of Non-Invasive Tests for Metabolic Liver Disease | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, cirrhosis of liver, fatty liver disease, hepatitis, liver disorder, metabolic dysfunction-associated steatohepatitis | Recruiting | Not stated | 2025-08-14 | NCT07122700 |